ALREX

This brand name is authorized in Brazil, Canada, Hong Kong, Singapore, United States, South Africa

Active ingredients

The drug ALREX contains one active pharmaceutical ingredient (API):

1 Loteprednol UNII YEH1EZ96K6 - LOTEPREDNOL ETABONATE

Loteprednol etabonate is a new class of corticosteroid with potent antiinflammatory activity designed to be active at the site of action. Its antiinflammatory activity is similar to the most powerful steroid used in ophthalmology but with less intraocular pressure. Read about Loteprednol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ALREX Ophthalmic suspension	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01BA14	Loteprednol	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain
Discover more medicines within S01BA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 503100801176418
Country: CA	Health Products and Food Branch	Identifier(s): 02320924
Country: HK	Department of Health Drug Office	Identifier(s): 54255
Country: SG	Health Sciences Authority	Identifier(s): 13427P
Country: US	FDA, National Drug Code	Identifier(s): 24208-353
Country: ZA	Health Products Regulatory Authority	Identifier(s): 38/15.2/0203